Clinical trials registration
2006

GSK's Commitment to Clinical Trial Transparency

Commentary

Author Information

Author(s): Frank W. Rockhold, Ronald L. Krall

Primary Institution: GlaxoSmithKline

Conclusion

GSK emphasizes the importance of registering clinical trial results to enhance transparency and improve patient care.

Supporting Evidence

  • GSK was the first company to establish a publicly available clinical trial register.
  • The register currently has over 2,000 records of GSK-sponsored clinical trials.
  • Industry made a commitment to disclose clinical trial information in January 2005.

Takeaway

GSK wants everyone to know about their clinical trials and the results, so doctors and patients can make better decisions.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030157

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication